Cargando…

A novel SLC25A1 inhibitor, parthenolide, suppresses the growth and stemness of liver cancer stem cells with metabolic vulnerability

Liver cancer stem cells (LCSCs) are recognized as key contributors to hepatocarcinogenesis, progression, and recurrence. Consequently, eradicating LCSCs has a great chance of increasing long-term survival in patients with liver cancer. Parthenolide (PTL), a natural sesquiterpene lactone product, pos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhichun, Qiao, Yuan, Sun, Qiuyue, Peng, Liang, Sun, Lichao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518014/ https://www.ncbi.nlm.nih.gov/pubmed/37741815 http://dx.doi.org/10.1038/s41420-023-01640-6

Ejemplares similares

Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis
por: Liu, Weifeng, et al.
Publicado: (2017)

Parthenolide Suppresses T Helper 17 and Alleviates Experimental Autoimmune Encephalomyelitis
por: Zhang, Zhihui, et al.
Publicado: (2022)

Suppression Of Aberrant Activation Of NF-κB Pathway In Drug-resistant Leukemia Stem Cells Contributes To Parthenolide-potentiated Reversal Of Drug Resistance In Leukemia
por: Yi, Juan, et al.
Publicado: (2021)

In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche
por: Zong, Hongliang, et al.
Publicado: (2015)

The DPY30-H3K4me3 Axis-Mediated PD-L1 Expression in Melanoma
por: Zhang, Zhichun, et al.
Publicado: (2022)

Parthenolide Inhibits Cancer Stem-Like Side Population of Nasopharyngeal Carcinoma Cells via Suppression of the NF-κB/COX-2 Pathway
por: Liao, Kun, et al.
Publicado: (2015)

Parthenolide Inhibits Angiogenesis in Esophageal Squamous Cell Carcinoma Through Suppression of VEGF
por: Tian, Bo, et al.
Publicado: (2020)

Suppression of tubulin detyrosination by parthenolide recruits the plant-specific kinesin KCH to cortical microtubules
por: Schneider, Natalie, et al.
Publicado: (2015)

Parthenolide plays a protective role in the liver of mice with metabolic dysfunction-associated fatty liver disease through the activation of the HIPPO pathway
por: Wang, Weihong, et al.
Publicado: (2021)

The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy
por: An, Tao, et al.
Publicado: (2022)

First Discovery of Cholesterol-Lowering Activity of Parthenolide as NPC1L1 Inhibitor
por: Liu, Wenjing, et al.
Publicado: (2022)

Parthenolide Inhibits STAT3 Signaling by Covalently Targeting Janus Kinases
por: Liu, Man, et al.
Publicado: (2018)

Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1/PI3K/AKT signaling
por: Hou, Yanli, et al.
Publicado: (2021)

Parthenolide reveals an allosteric mode to inhibit the deISGylation activity of SARS-CoV‑2 papain-like protease: Parthenolide covalently inhibits papain-like protease
por: Zou, Zhihui, et al.
Publicado: (2022)

The therapeutic effect and mechanism of parthenolide in skeletal disease, cancers, and cytokine storm
por: Zhu, Sipin, et al.
Publicado: (2023)

Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis
por: Carlisi, D, et al.
Publicado: (2016)

Box–Behnken Design (BBD)-Based Optimization of Microwave-Assisted Extraction of Parthenolide from the Stems of Tarconanthus camphoratus and Cytotoxic Analysis
por: Alam, Perwez, et al.
Publicado: (2021)

Parthenolide generates reactive oxygen species and autophagy in MDA-MB231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer
por: D'Anneo, A, et al.
Publicado: (2013)

Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway
por: Lin, Minting, et al.
Publicado: (2017)

Parthenolide inhibits the growth of non-small cell lung cancer by targeting epidermal growth factor receptor
por: Li, Xiaoling, et al.
Publicado: (2020)

(E)-13-(4-Aminophenyl)parthenolide
por: Penthala, Narsimha Reddy, et al.
Publicado: (2013)

Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia
por: Li, Xingjian, et al.
Publicado: (2019)

Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies
por: Jorge, Joana, et al.
Publicado: (2023)

SLC25A21 Suppresses Cell Growth in Bladder Cancer via an Oxidative Stress-Mediated Mechanism
por: Wang, Yong, et al.
Publicado: (2021)

Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver
por: González-Moreno, Luis, et al.
Publicado: (2023)

The lipid flippase SLC47A1 blocks metabolic vulnerability to ferroptosis
por: Lin, Zhi, et al.
Publicado: (2022)

SLC25A1 promotes tumor growth and survival by reprogramming energy metabolism in colorectal cancer
por: Yang, Ying, et al.
Publicado: (2021)

Cell death in amastigote forms of Leishmania amazonensis induced by parthenolide
por: Tiuman, Tatiana Shioji, et al.
Publicado: (2014)

Crystal structure of (E)-13-(pyrimidin-5-yl)parthenolide
por: Bommagani, Shobanbabu, et al.
Publicado: (2015)

Parthenolide: a novel pharmacological approach to promote nerve regeneration
por: Diekmann, Heike, et al.
Publicado: (2016)

Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies
por: Sztiller-Sikorska, Malgorzata, et al.
Publicado: (2020)

Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties
por: Carlisi, Daniela, et al.
Publicado: (2022)

Restoring MLL reactivates latent tumor suppression-mediated vulnerability to proteasome inhibitors
por: Ge, Maolin, et al.
Publicado: (2020)

SLC7A11 as a Gateway of Metabolic Perturbation and Ferroptosis Vulnerability in Cancer
por: Lee, Jaewang, et al.
Publicado: (2022)

Decreased SLC27A5 Suppresses Lipid Synthesis and Tyrosine Metabolism to Activate the Cell Cycle in Hepatocellular Carcinoma
por: Wang, Jiyan, et al.
Publicado: (2022)

Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation
por: Lee, Jae-Seon, et al.
Publicado: (2019)

The mitochondrial transporter SLC25A25 links ciliary TRPP2 signaling and cellular metabolism
por: Hofherr, Alexis, et al.
Publicado: (2018)

Down-regulation of SLC25A20 promotes hepatocellular carcinoma growth and metastasis through suppression of fatty-acid oxidation
por: Yuan, Peng, et al.
Publicado: (2021)

Comparative effects of the herbal constituent parthenolide (Feverfew) on lipopolysaccharide-induced inflammatory gene expression in murine spleen and liver
por: Smolinski, Alexa T, et al.
Publicado: (2005)

Association between expression of Carboxypeptidase 4 and stem cell markers and their clinical significance in liver cancer development
por: Sun, Lichao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_oq1b8fthbads3m88g4t8s5g7a9